BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 26555371)

  • 21. Human or animal homograft: could they have a future as a biological scaffold for engineered heart valves?
    Dainese L; Biglioli P
    J Cardiovasc Surg (Torino); 2010 Jun; 51(3):449-56. PubMed ID: 20523298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of human umbilical cord blood-derived progenitor cells for tissue-engineered heart valves.
    Sodian R; Schaefermeier P; Abegg-Zips S; Kuebler WM; Shakibaei M; Daebritz S; Ziegelmueller J; Schmitz C; Reichart B
    Ann Thorac Surg; 2010 Mar; 89(3):819-28. PubMed ID: 20172137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological and mechanical evaluation of a Bio-Hybrid scaffold for autologous valve tissue engineering.
    Jahnavi S; Saravanan U; Arthi N; Bhuvaneshwar GS; Kumary TV; Rajan S; Verma RS
    Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():59-71. PubMed ID: 28183649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluid mechanics of heart valves.
    Yoganathan AP; He Z; Casey Jones S
    Annu Rev Biomed Eng; 2004; 6():331-62. PubMed ID: 15255773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue engineering of heart valves: biomechanical and morphological properties of decellularized heart valves.
    Tudorache I; Cebotari S; Sturz G; Kirsch L; Hurschler C; Hilfiker A; Haverich A; Lichtenberg A
    J Heart Valve Dis; 2007 Sep; 16(5):567-73; discussion 574. PubMed ID: 17944130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decellularized tissue-engineered heart valves calcification: what do animal and clinical studies tell us?
    Badria AF; Koutsoukos PG; Mavrilas D
    J Mater Sci Mater Med; 2020 Dec; 31(12):132. PubMed ID: 33278023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From stem cells to viable autologous semilunar heart valve.
    Sutherland FW; Perry TE; Yu Y; Sherwood MC; Rabkin E; Masuda Y; Garcia GA; McLellan DL; Engelmayr GC; Sacks MS; Schoen FJ; Mayer JE
    Circulation; 2005 May; 111(21):2783-91. PubMed ID: 15927990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is Transcatheter Aortic Valve Implantation of Living Tissue-Engineered Valves Feasible? An In Vitro Evaluation Utilizing a Decellularized and Reseeded Biohybrid Valve.
    Koenig F; Lee JS; Akra B; Hollweck T; Wintermantel E; Hagl C; Thierfelder N
    Artif Organs; 2016 Aug; 40(8):727-37. PubMed ID: 27187768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of: application of synthetic scaffold in tissue engineering heart valves.
    Fallahiarezoudar E; Ahmadipourroudposht M; Idris A; Mohd Yusof N
    Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():556-65. PubMed ID: 25579957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute.
    Breuer CK; Mettler BA; Anthony T; Sales VL; Schoen FJ; Mayer JE
    Tissue Eng; 2004; 10(11-12):1725-36. PubMed ID: 15684681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro generation of atrioventricular heart valve neoscaffolds.
    Weymann A; Radovits T; Schmack B; Li S; Korkmaz S; Soós P; Istók R; Veres G; Chaimow N; Karck M; Szabó G
    Artif Organs; 2014 Jul; 38(7):E118-28. PubMed ID: 24842040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tissue engineering for heart valves and vascular grafts].
    Teebken OE; Wilhelmi M; Haverich A
    Chirurg; 2005 May; 76(5):453-66. PubMed ID: 15841408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fabrication and In Vitro Characterization of a Tissue Engineered PCL-PLLA Heart Valve.
    Hasan A; Soliman S; El Hajj F; Tseng YT; Yalcin HC; Marei HE
    Sci Rep; 2018 May; 8(1):8187. PubMed ID: 29844329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart valve tissue engineering.
    Vesely I
    Circ Res; 2005 Oct; 97(8):743-55. PubMed ID: 16224074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth.
    Weber B; Zeisberger SM; Hoerstrup SP
    Placenta; 2011 Oct; 32 Suppl 4():S316-9. PubMed ID: 21575988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcatheter tissue engineered heart valves.
    Emmert MY; Weber B; Falk V; Hoerstrup SP
    Expert Rev Med Devices; 2014 Jan; 11(1):15-21. PubMed ID: 24308737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Heart valve and myocardial tissue engineering].
    Cebotari S; Tudorache I; Schilling T; Haverich A
    Herz; 2010 Aug; 35(5):334-41. PubMed ID: 20631970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EMT-inducing biomaterials for heart valve engineering: taking cues from developmental biology.
    Sewell-Loftin MK; Chun YW; Khademhosseini A; Merryman WD
    J Cardiovasc Transl Res; 2011 Oct; 4(5):658-71. PubMed ID: 21751069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart valve tissue engineering.
    Neuenschwander S; Hoerstrup SP
    Transpl Immunol; 2004 Apr; 12(3-4):359-65. PubMed ID: 15157927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source.
    Schmidt D; Achermann J; Odermatt B; Breymann C; Mol A; Genoni M; Zund G; Hoerstrup SP
    Circulation; 2007 Sep; 116(11 Suppl):I64-70. PubMed ID: 17846327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.